Plain-English translation of NCT07042581 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether , a vaginal health product, can safely and effectively reduce vaginal dryness and discomfort in people being treated for hormone-receptor-positive breast cancer. Vaginal dryness is a common side effect of breast cancer medications, and this study aims to see if the medication can improve quality of life and comfort during and after treatment.
Many breast cancer patients experience vaginal dryness and pain during or after treatment, which can affect their quality of life and relationships. Researchers want to know if this treatment can safely help ease these symptoms without interfering with cancer care.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will use as directed while continuing your regular breast cancer medications and follow-up care. You will complete questionnaires about your vaginal symptoms and overall comfort at study visits. The study will help researchers understand whether this treatment can safely improve vaginal health in breast cancer patients.
AI-generated summary from trial data · Aug 28, 2026 · Not medical advice
United States